VARILEK JAMES A
Known title: EVP & COOCIK: 0001654938
Associated companies
Transaction History
| OLN | ▲ Buy | Option Exercise | 50,000 | $866K | 11/18/2022 | View on chart |
| OLN | ▼ Sell | Open Market | 50,000 | $2.8M | 11/18/2022 | View on chart |
| OLN | ▼ Sell | Open Market | 3,345 | $193K | 8/18/2022 | View on chart |
| OLN | ▲ Buy | Option Exercise | 19,418 | — | 8/17/2022 | View on chart |
| OLN | ▼ Sell | Other | 19,418 | $1.1M | 8/17/2022 | View on chart |
| OLN | ▲ Buy | Option Exercise | 28,265 | $742K | 5/27/2022 | View on chart |
| OLN | ▼ Sell | Open Market | 28,265 | $1.8M | 5/27/2022 | View on chart |
| OLN | ▲ Buy | Option Exercise | 1,602 | $42K | 5/26/2022 | View on chart |
| OLN | ▼ Sell | Open Market | 1,602 | $104K | 5/26/2022 | View on chart |
| OLN | ▼ Sell | Gift | 12,383 | $0 | 4/6/2022 | View on chart |
| OLN | ▲ Buy | Option Exercise | 5,000 | $0 | 4/1/2022 | View on chart |
| OLN | ▼ Sell | Tax Withholding | 2,233 | $119K | 4/1/2022 | View on chart |
| OLN | ▲ Buy | Grant | 14,935 | $0 | 2/22/2022 | View on chart |
| OLN | ▲ Buy | Option Exercise | 25,005 | $657K | 11/3/2021 | View on chart |
| OLN | ▼ Sell | Open Market | 25,005 | $1.5M | 11/3/2021 | View on chart |
| OLN | ▲ Buy | Option Exercise | 66,000 | $2.0M | 11/3/2021 | View on chart |
| OLN | ▼ Sell | Open Market | 66,000 | $4.0M | 11/3/2021 | View on chart |
| OLN | ▲ Buy | Option Exercise | 34,728 | $912K | 9/1/2021 | View on chart |
| OLN | ▼ Sell | Open Market | 30,000 | $1.5M | 9/1/2021 | View on chart |
| OLN | ▼ Sell | Open Market | 4,728 | $246K | 9/1/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 12, 2026
UBS Cuts Olin Target to $18, Awaits Q3 Earnings
UBS has lowered its price target for Olin to $18 while maintaining a Neutral rating. This move comes just ahead of the company's Third Quarter 2026 earnings conference call. The stock is currently trading near its 52-week low, with an average analyst target of $20.20.
UBS Cuts Olin Target to $18, Awaits Q3 Earnings. UBS has lowered its price target for Olin to $18 while maintaining a Neutral rating. This move comes just ahead of the company's Third Quarter 2026 earnings conference call. The stock is currently trading near its 52-week low, with an average analyst target of $20.20.